Previous 10 | Next 10 |
2023-11-06 15:44:53 ET Summary The iShares U.S. Pharmaceuticals ETF provides targeted exposure to the U.S. pharmaceutical industry but has a highly concentrated portfolio. The IHE ETF's top five holdings, including Eli Lilly and Johnson & Johnson, account for over 63% of the f...
2023-11-06 15:01:08 ET More on J&J, Pfizer, etc. Pfizer: Value Investment Opportunity After Recent Price Decline Pfizer Inc. (PFE) Q3 2023 Earnings Call Transcript Pfizer Inc. 2023 Q3 - Results - Earnings Call Presentation Viatris Q3 2023 Earnings Preview...
2023-11-06 12:59:29 ET More on Viatris Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss Theravance, Mylan settle patent...
2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...
2023-10-31 05:05:00 ET As you may have heard, Novo Nordisk (NYSE: NVO) makes Ozempic, the type 2 diabetes medication sweeping the globe and raking in billions in the process. Where there's a money-printing drug in ascent, there's almost always a dispute about exactly who is the righ...
2023-10-30 18:50:40 ET More on Theravance Biopharma, Teva Pharmaceutical, etc. Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss...
Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance PR Newswire PITTSBURGH , Oct. 30, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today it is hosting The Power of Partnership to ...
2023-10-29 12:00:27 ET More on PBMs Cigna PBM unit Express Scripts sued for overcharging pharmacies FTC investigating purchasing organizations that work on behalf of PBMs Eli Lilly, Novo, Sanofi and leading PBMs accused in California over insulin prices CVS H...
2023-10-23 13:41:19 ET More on Viatris Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss 4 stocks to watch on Monday: Vi...
Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row PR Newswire PITTSBURGH , Oct. 23, 2023 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forb...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...